FDA approves 1st peanut allergy drug for kids

For the first time, kids with peanut allergies have a treatment option that could help them reduce the risk of allergic reactions.

On Friday, the Food and Drug Administration approved Palforzia, the first peanut allergy drug for kids. Peanuts are one of the most common food allergies in the United States, with about one million children affected, the FDA says. Only one out of five kids will outgrow their allergy. Children with allergies can experience severe reactions, including hives, swelling, and fainting, even when exposed to the smallest amount of peanut.

Palforzia is approved for use by kids 4 through 17. While under a doctor's care, patients will ingest controlled dosages of the drug, which is made of peanut protein. If they tolerate the drug, patients will take it for several months, eventually reaching a daily maintenance dose. Palforzia is not a cure and patients will still need to avoid peanuts, but their risk of allergic reaction will be reduced.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up